Depressive disorder
|
0.450 |
Biomarker
|
disease |
HPO |
|
|
|
Depressive disorder
|
0.450 |
Biomarker
|
disease |
PSYGENET |
Candidate genes, such as those encoding for the brain-derived neurotrophic factor (BDNF), serotonin transporter (5-HTT), and Period2 (PER2), have been associated with depression and seasonal disorders.
|
21997575 |
2011 |
Depressive disorder
|
0.450 |
Biomarker
|
disease |
BEFREE |
Candidate genes, such as those encoding for the brain-derived neurotrophic factor (BDNF), serotonin transporter (5-HTT), and Period2 (PER2), have been associated with depression and seasonal disorders.
|
21997575 |
2011 |
Depressive disorder
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
In a cohort of 361 Caucasians, the severity of depression was assessed prospectively during pregnancy (third trimester) and the postpartum period (2-3 days and 6-8 months) using the Edinburgh Postnatal Depression Scale (EPDS).
|
22721547 |
2012 |
Depressive disorder
|
0.450 |
Biomarker
|
disease |
PSYGENET |
In a cohort of 361 Caucasians, the severity of depression was assessed prospectively during pregnancy (third trimester) and the postpartum period (2-3 days and 6-8 months) using the Edinburgh Postnatal Depression Scale (EPDS).
|
22721547 |
2012 |
Depressive disorder
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
In a non-psychiatric cohort of 419 Caucasians, the severity of depression was assessed prospectively during pregnancy (3rd trimester) and the postpartum period (2-3 days and 6-8 months) using the Edinburgh Postnatal Depression Scale.
|
22209125 |
2012 |
Depressive disorder
|
0.450 |
Biomarker
|
disease |
PSYGENET |
In a non-psychiatric cohort of 419 Caucasians, the severity of depression was assessed prospectively during pregnancy (3rd trimester) and the postpartum period (2-3 days and 6-8 months) using the Edinburgh Postnatal Depression Scale.
|
22209125 |
2012 |
Depressive disorder
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, genetic variation in PER2 is associated with depression vulnerability a Swedish population-based sample.
|
19693801 |
2010 |
Depressive disorder
|
0.450 |
Biomarker
|
disease |
PSYGENET |
Per1, Per2) represent key regulators of circadian rhythmicity, and their targeted disruption in mutant mice produces potentiated reward drive, novelty-seeking, impulsivity, disrupted sleep, reduced depression and anxiety - a behavioral profile highly reminiscent of our selectively bred high responder (bHR) rats compared to bred low responders (bLRs).
|
21775066 |
2012 |
Depressive disorder
|
0.450 |
AlteredExpression
|
disease |
BEFREE |
Questionnaires about quality of life (EuroQoL EQ-5D-5 L, the European Organization For Research And Treatment Of Cancer Core Quality Of Life Questionnaire EORTC QLQ-C30 join to the specific breast cancer module (QLQ-BR23), as well as Hospital Anxiety and Depression Scale were completed by the patients before the beginning of the initial treatment and at the end of follow-up period, 2 years later.
|
29310641 |
2018 |
Depressive disorder
|
0.450 |
Biomarker
|
disease |
PSYGENET |
Recent findings concerning the statistical laws of behavioral organization shared between healthy humans and wild-type mice (WT) and their alterations in human depression patients and circadian clock gene (Period 2; Per2) mutant mice indicate that clock genes play functional roles in intermittent, ultradian locomotor dynamics.
|
23516567 |
2013 |